Methylphenidate abuse in Texas, 1998-2004

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 69, Issue 12, 2006, Pages 1145-1153

  Forrester, Mathias ^a  

^a TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; DRUG ABUSE; DRUG IDENTIFICATION; ENVIRONMENTAL EXPOSURE; FEMALE; GEOGRAPHY; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; POISON CENTER; PRIORITY JOURNAL; SCHOOL; UNITED STATES; ADDICTION; AGE; CHILD BEHAVIOR; SEX DIFFERENCE; STATISTICS; TELEPHONE;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; HOTLINES; HUMANS; MALE; METHYLPHENIDATE; POISON CONTROL CENTERS; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; TEXAS;

EID: 33745244771     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390500360273     Document Type: Article

References (21)

1. Bailey, B., Letarte, A., and Abran, M. C. 2003. Methylphenidate ingestion in pre-school children: A case series. J. Toxicol. Clin. Toxicol. 41:657-658.
2. Bond, G. R. 2002. TESS and teen drug abuse: using prescription ADHD drugs to examine the utility of Toxic Exposure Surveillance System. J. Toxicol. Clin. Toxicol. 40:652-653.
3. Bond, G. R. 2003. Surveillance monitoring for emerging trends in drug abuse. J. Toxicol. Clin. Toxicol. 41:458-490.
4. Foley, R., Mrvos, R., and Krenzelok, E. P. 2000. A profile of methylphenidate exposures. J. Toxicol. Clin. Toxicol. 38:625-630.
5. Goldman, L. S., Genel, M., Bezman, R. J., and Slanetz, P. J. 1998. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. J. Am. Med. Assoc. 279:1100-1107.
6. Hopkins, U., Klein-Schwartz, W., Anderson, B., and Sailley, A. 1999. Methylphenidate exposures: 5 Years of poison center experience. J. Toxicol. Clin. Toxicol. 37:648.
7. Johnston, L. D., O'Malley, P. M., and Bachman, J. G. 2001. Monitoring the Future National Survey results on drug abuse, 1975-2000, Vol. 1, Secondary school students (NIH Publication 01-4924). Bethesda, MD: National Institute on Drug Abuse.
8. Kimko, H. C., Cross, J. T., and Abernethy, D. R. 1999. Pharmacokinetics and clinical effectiveness of methylphenidate. Clin. Pharmacokinet. 37:457-470.
9. Klein-Schwartz, W. 2003. Pediatric methylphenidate exposures: 7-Year experience of poison centers in the United States. Clin. Pediatr. (Phila.) 42:159-164.
10. Klein-Schwartz, W., and McGrath, J. 2003. Poison centers' experience with methylphenidate abuse in pre-teens and adolescents. J. Am. Acad. Child. Adolesc. Psychiat. 42:288-294.
11. Koller, M., Schnorf-Huber, S., Kupferschmidt, H., and Meier-Abt, P. J. 2002. Acute toxicity of oral methylphenidate (MP) overdose in Switzerland. J. Toxicol. Clin. Toxicol. 40:276.
12. Krummen, K., Tsipis, G., Siegel, E., and Bottei, E. 1999. Accuracy of drug abuse call patterns in predicting prescription drug abuse. J. Toxicol. Clin. Toxicol. 37:643.
13. Marquardt, K. A., Alsop, J. A., Lamb, J. P., Lai, C., Walsh, M. J., and Albertson, T. E. 2004. Methylphenidate ingestions: Comparison of drug formulations. J. Toxicol. Clin. Toxicol. 42:728.
14. McKeithan, E. K., and Shepherd, M. D. 1996. Pharmaceutical products declared by US residents on returning to the United States from Mexico. Clin. Ther. 18:1242-1251.
15. Mrvos, R., and Krenzelok, E. P. 2002. Surveillance of drug identification calls: An overlooked poison center responsibility. Vet. Hum. Toxicol. 44:294-295.
16. Muller, A. A. 2003. Pill identification: Rethinking the poison center's role. J. Toxicol. Clin. Toxicol. 41:680-681.
17. Safer, D. J., Zito, J. M., and Fine, E. M. 1996. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 98:1084-1088.
18. Slattery, A., and King, W. 1998. Poison center drug identification call. J. Toxicol. Clin. Toxicol. 36:484.
19. Valdez, A., Cepeda, A., Kaplan, C. D., and Yin, Z. 1998. The legal importation of prescription drugs into the United States from Mexico: A study of Customs declaration forms. Subst. Use Misuse 33:2485-2497.
20. White, S. R., and Yadao, C. M. 2000. Characterization of methylphenidate exposures reported to a regional poison control center. Arch. Pediatr. Adolesc. Med. 154:1199-1203.
21. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Boles, M., and Lynch, F. 2000. Trends in the prescribing of psychotropic medications to preschoolers. J. Am. Med. Assoc. 283:1025-1030.